Successful treatment of reactive arthritis with a humanized anti-interleukin-6 receptor antibody, tocilizumab

Arthritis Rheum. 2009 Dec 15;61(12):1762-4. doi: 10.1002/art.24899.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Reactive / diagnosis
  • Arthritis, Reactive / drug therapy*
  • Arthritis, Reactive / physiopathology
  • Citrates
  • Female
  • Gallium
  • Health Status
  • Humans
  • Joints / drug effects
  • Joints / physiopathology
  • Radionuclide Imaging
  • Receptors, Interleukin-6 / antagonists & inhibitors*
  • Receptors, Interleukin-6 / immunology
  • Severity of Illness Index
  • Treatment Outcome
  • Young Adult

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Citrates
  • Receptors, Interleukin-6
  • Gallium
  • gallium citrate
  • tocilizumab